Company:  AYTU BIOPHARMA, INC (AYTU)
Form Type:  424B5
Filing Date:  6/7/2021 
CIK:  0001385818 
Address:  373 INVERNESS PARKWAY
SUITE 206
 
City, State, Zip:  ENGLEWOOD, Colorado 80112 
Telephone:  (720) 437-6580 
Fiscal Year:  06/30 
Last Trade
Last Trade: 
$2.46  
Change: 
-0.10 (-3.91%)  
Trade Time: 
Oct 22  
Market Cap: 
$67.78M
Trade AYTU now with

© 2021  
Description of Business
We are a commercial-stage specialty pharmaceutical company focused on commercializing novel products that address needs in both prescription and consumer health categories. Through our prescription business, and following our recent merger with Neos Therapeutics, Inc. ("Neos"), which closed on March 19, 2021, we market a portfolio of prescription products addressing large markets with a focus on general pediatric conditions, attention deficit/hyperactivity disorder ("ADHD") and insomnia. We also market a portfolio of consumer health products also addressing large categories through our consumer health subsidiary, acquired in February 2020. Our goal is to become a leading specialty pharmaceutical company focused on large prescription and consumer health categories while building a late-stage development pipeline addressing significant medical needs.
Register and access this filing in:     
  FORM 424B5
    TABLE OF CONTENTS
    ABOUT THIS PROSPECTUS SUPPLEMENT
    FORWARD-LOOKING STATEMENTS
    THE OFFERING
    RISK FACTORS
    USE OF PROCEEDS
    DILUTION
    PLAN OF DISTRIBUTION
    LEGAL MATTERS
    EXPERTS
    WHERE YOU CAN FIND ADDITIONAL INFORMATION
      DOCUMENTS INCORPORATED BY REFERENCE
    RISK FACTORS
    USE OF PROCEEDS
    DESCRIPTION OF DEBT SECURITIES
    DESCRIPTION OF CAPITAL STOCK
    Transfer Agent and Registrar
    DESCRIPTION OF OTHER SECURITIES
    By Underwriters